Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cannapharmarx Inc (OP: CPMD )

0.0033 +0.0003 (+10.00%)
Streaming Delayed Price Updated: 9:36 AM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cannapharmarx Inc

< Previous 1 2 Next >
CannapharmaRx to Complete Additional Shipment in November
Via ACCESSWIRE
CannaPharmaRx Receives Multiple Purchase Orders and Begins Delivery of Product
Via ACCESSWIRE
Q1 2024 Financial Results
Via ACCESSWIRE
CORRECTION FROM SOURCE: CannaPharmaRx to Host Investor Conference Call
Via ACCESSWIRE
CannaPharmaRx to Host Investor Conference Call
Via ACCESSWIRE
CannapharmaRx Pays Off Convertible Notes
Via ACCESSWIRE
CannapharmaRx Receives First Purchase Order and Begins Shipment of Product
Via ACCESSWIRE
CannaPharmaRx CEO Provides Annual Update Message
Via ACCESSWIRE
CannaPharmaRx Completes First Harvests
Via ACCESSWIRE
CannaPharmaRx to Hold Investor Conference Call
Via ACCESSWIRE
Cannapharmarx Partners With ICAN To Expand Cannabis Distribution In Latin America
CannaPharmaRx and ICAN form a strategic partnership to bolster cannabis distribution in Latin America, focusing on Mexico and Panama. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
CannaPharmaRx Executes Multi-Year Supply Agreement with ICAN to Create Distribution Network in the Latin Americas
Via ACCESSWIRE
CannaPharmaRx Achieves IMC-GAP and GACP Certifications Completing a Significant Milestone Towards Revenue Acceleration
Via ACCESSWIRE
CannaPharmaRx Finalizes Multi-Million Dollar Israeli Supply Agreement with Cantek
Via ACCESSWIRE
Cannabis Industry Changes As Marijuana Rescheduling Looms
As the Benzinga Cannabis Capital Conference returns to Chicago this Sept 27-28 for its 17th edition, gathering top CEOs, investors and leaders in the cannabis industry, let's scroll through the top... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
CannaPharmaRx Expands Board of Directors
Via ACCESSWIRE
Cannabis Movers & Shakers: Delaware's New Marijuana Commissioner And Latest Industry Appointments
Delaware Governor's Pick For Marijuana Commissioner Confirmed 
Via Benzinga
CannaPharmaRx Appoints Dean Medwid as New CEO
Via ACCESSWIRE
CannaPharmaRx Signs Agreement with Nasha Genetics
Via ACCESSWIRE
CannaPharmaRx Signs Supply Agreement With Y.S.A For Up To $15M Annually Of Commercial Cannabis
CannaPharmaRx, Inc. (OTCPK:CPMD) has signed a supply agreement with Israeli company Y.S.A Holdings. The business arrangement sets forth a supply agreement between the two companies. 
Via Benzinga
CannaPharmaRx Signs Supply Agreement with Y.S.A Holdings for up to $15 Million Annually of Commercial Cannabis
Via ACCESSWIRE
New Leaf Ventures Enters Into Genetics Supply Agreement With CannaPharmaRX
High Profile Holdings Cannabis Corp., a wholly-owned subsidiary of New Leaf Ventures Inc. (OTCPK:NLVVF) (CSE:NLV) has executed a genetics transfer and buyback agreement with CannaPharmaRX Inc.... 
Via Benzinga
CannaPharmRx, Inc. Completes Purchase of LTB Management, an E- Commerce and Financial Platform Company, and Launches New Corporate Website
Via ACCESSWIRE
CannaPharmRx, Inc. Adds to Revenue Streams by Purchasing E-Commerce and Financial Platform Company
Via ACCESSWIRE
CannaPharmaRx Evaluates Investigation into Market Manipulation and Potentially Illegal Trading of Stock
Via ACCESSWIRE
CannaPharmaRx Releases Year-in-Review Letter to Shareholders and Discusses Revenue Opportunities for 2023
Via ACCESSWIRE
CannaPharmaRx Receives Canada Revenue Agency (CRA) License As Final Step to Bringing Facility Into Production With Annual Revenues of Over $30 Million Expected
Via ACCESSWIRE
Canadian Cannabis; Down but Far from Out - Growth for 2023 and Beyond
Vancouver, Kelowna, and Delta, British Columbia--(Newsfile Corp. - December 22, 2022) - Investorideas.com, a leading investor news resource covering cannabis... 
Via Newsfile
Topics Cannabis
Exposures Cannabis
CannaPharmaRx Receives Cultivation License from Health Canada and Projects 2023 Revenue Over $30 Million
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Cannabis
Exposures Cannabis
CannaPharmaRx Receives Cultivation License from Health Canada and Projects 2023 Annual Revenue over $30 Million
Via ACCESSWIRE
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.